Vaxart에 대한 매도 수량은 투자자에게 Vaxart의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Vaxart (NASDAQ:VXRT) 주식, 공매도 수량 보고

Vaxart

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Rising Infections Across The U.S.

Biotech

News

Health Care

After-Hours Center

Movers

VXRT

백사트(NASDAQ:VXRT)의 주가는 회사가 비즈니스 및 현금 런웨이(스타트업의 생존 가능 기간) 업데이트를 제공한 후 월요일 시간외 거래에서 상승했다.

백사트 주가는 회사가 현금 런웨이 업데이트를 제공한 후 상승

Earnings

PANW

월요일 시장 마감 후 팔로알토 네트웍스(NASDAQ:PANW)의 3분기 재무 결과가 발표됐다. 이 보고서의 주요 내용을 살펴보자. 주요 정보 (The Details): 팔로알토 네트웍스의 분기별 주당 순이익은 1.32달러로, 이는 1.25달러로 예상했던 애널리스트 컨센서스를 5.6% 상회했다.

팔로알토 네트웍스: 3분기 실적과 4분기 및 연간 전망 발표 후 주가 하락

Vaxart Inc

The Ultimate Fighting Championship (UFC), a subsidiary of TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>), has entered into a multi-year partnership with tech giant Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) to transform fan engagement using Meta&#8217;s advanced technology.
What Happened: The UFC announced that Mark Zuckerberg&#8216;s Meta is now the UFC&#8217;s first Official Fan Technology Partner. The partnership will utilize Meta&#8217;s technology platforms, services, and products, such as Facebook, Instagram, WhatsApp, Threads, Meta AI, Meta Glasses, and Meta Quest, to deliver an unparalleled immersive UFC experience for fans.
Meta will also serve as the Official AI Glasses Partner of UFC, bringing the innovative application of its AI glasses to UFC events. &#8220;Mark and his team at&nbsp;Meta are going to do&nbsp;things that will blow away&nbsp;UFC fans,&#8221;&nbsp;said UFC President and CEO&nbsp;Dana White.
The partnership will incorporate Meta into UFC assets through extensive activations across all Pay-Per-Views and Fight Nights, featuring brand placement in the Octagon&#xAE;, multiple broadcast integrations, and engaging in-arena fan experiences. 
Threads, Meta&#8217;s text-based platform for public discussions, will be an Official Social Media Partner of the UFC, acting as the main hub for the UFC community and offering exclusive original content.
See Also: <a href="https://benzinga.com/25/04/44605992/whats-going-on-with-carvana-stock-today" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Carvana Stock Today?</a>
Why It Matters: This partnership marks a significant step for Meta in its quest to expand beyond being a social media powerhouse. The partnership with UFC, which has a global fan base exceeding 700 million and over 300 million social media followers, could greatly accelerate Meta&#8217;s expansion into wearable technology, especially in virtual and augmented reality.
Meta&#8217;s Ray-Ban smart glasses, launched in late 2023, have sold over 2 million units. While not a major revenue source yet, they are strategically important for Meta's AI ambitions. Powered by the Llama AI model, the glasses and Meta AI chatbot aim to enhance user engagement and improve ad targeting.
CNBC&#8217;s Paulina Likos stated, &#8220;Big picture Zuckerberg has a long-term vision that smart glasses could be the next computing platform, much like the smartphone ushered in the mobile computing era.&#8221;
Interestingly, this development comes on the heels of the news that <a href="https://www.benzinga.com/25/04/44602810/metas-ai-chief-announces-departure-while-mark-zuckerberg-doubles-down-on-ai-investments">Meta&#8217;s AI Chief</a>, Joelle Pineau, is exiting the company in May. 
Meta holds a momentum rating of 80.75% and a growth rating of 74.80%, according to&nbsp;<a href="https://www.benzinga.com/quote/META" target="_blank" rel="noreferrer noopener">Benzinga's Proprietary Edge Rankings</a>. For an in-depth report on more stocks and insights into growth opportunities,&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">sign</a>&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">up for Benzinga Edge.</a>
<ul>
<li>Read Next: <a href="https://benzinga.com/trading-ideas/movers/25/04/44614272/nvidia-stock-is-down-nearly-20-ytd-whats-going-on" target="_blank" rel="noreferrer noopener">Nvidia Stock Is Down Nearly 20% YTD: What&#8217;s Going On?</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Tech

NVDA

UFC Picks Mark Zuckerberg's Meta As Official Technology Partner, Joins Forces To Revolutionize Fan Engagement: 'Smart Glasses Could Be The Next Computing Platform'

Macro Economic Events

Econ #s

Economics

Eurozone Services Purchasing Managers Index For March 51.0 Vs. 50.4 Est.; 50.6 Prior

HCOB Eurozone Composite Purchasing Managers Index For March 50.9 Vs. 50.4 Est.; 50.2 Prior

Germany Services Purchasing Managers Index For March 50.9 Vs. 50.2 Est.; 51.1 Prior

France Services Purchasing Managers Index For March 47.9 Vs. 46.6 Est.; 45.3 Prior

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Acuity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) to report quarterly earnings at $3.70 per share on revenue of $1.03 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Acuity shares fell 2% to $261.05 in after-hours trading.</li>
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) reported weaker-than-expected fourth-quarter financial results after the market closed on Wednesday. RH reported fourth-quarter revenue of $812.41 million, missing the consensus estimate of $829.56 million, according to Benzinga Pro. The luxury retailer reported fourth-quarter adjusted earnings of $1.58 per share, missing analyst estimates of $1.92 per share. RH shares dipped 26.1% to $184.40 in the after-hours trading session.</li>
<li>Analysts are expecting Conagra Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) to post quarterly earnings at 53 cents per share on revenue of $2.90 billion. The company will release earnings before the markets open. Conagra shares fell 0.9% to $26.14 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Penguin Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) posted better-than-expected results for its second quarter on Wednesday. The company said it sees FY25 net sales growth of 17% year-over-year +/-3% and adjusted EPS of $1.60 +/- $0.10. Penguin Solutions shares gained 4.6% to $18.88 in the after-hours trading session.</li>
<li>Analysts expect Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) to post quarterly earnings at $1.70 per share on revenue of $86.09 billion after the closing bell. Exxon Mobil shares fell 2.3% to $115.91 in the after-hours trading session.</li>
</ul>
Check This Out:
<ul>
<li> <a href="https://www.benzinga.com/25/04/44604078/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Trading Ideas

Penguin Solutions, Inc. - Ordinary Shares

PENG

Acuity, RH And 3 Stocks To Watch Heading Into Thursday

As President Donald Trump lights the global economy on fire in his bid to <a href="https://www.benzinga.com/markets/25/04/44621408/market-access-has-a-price-trump-unveils-list-of-tariffs-countries-targeted">reduce America&#8217;s $1.2 trillion annual trade deficit</a>, a few astute observers on X have uncovered the math that went into arriving at the tariffs that other countries charge the United States, which ultimately led to the reciprocal tariffs that the US will now be imposing on them.
What Happened: A post questioned Trump&#8217;s credibility on the subject of tariffs. James Surowiecki, a writer for The Atlantic and Fast Company had a tough time making sense of some of the figures shared by the White House on Wednesday evening, especially those about tariffs imposed by other countries on American exports.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Even given that it&#39;s Trump, I cannot believe they said &quot;We&#39;ll just divide the trade deficit by imports and tell people that&#39;s the tariff rate.&quot; And then they decided to set our tariffs by just cutting that totally made-up rate in half! This is so dumb and deceptive.
&mdash; James Surowiecki (@JamesSurowiecki) <a href="https://twitter.com/JamesSurowiecki/status/1907560211365167246?ref_src=twsrc%5Etfw">April 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He knew something wasn&#8217;t adding up, since South Korea, a country with which the US has a trade agreement was not charging 50% tariffs on US exports, as reported in the graphic released by the White House. After initially chalking it all up to made-up figures, he soon arrived at the absurd calculations that went into them.
See More: <a href="https://www.benzinga.com/25/04/44621914/trump-reportedly-imposes-tariffs-on-uninhabited-islands-and-remote-locations-world-bank-data-raises-questions">Trump Imposes Tariffs On Uninhabited Islands And Remote Locations: World Bank Data Raises Questions</a>
Surowiecki says that the tariff figures were calculated by merely dividing the US&#8217; trade deficit with a particular country by the said country&#8217;s total exports to the U.S. He even went on to illustrate it by giving the example of Indonesia, on which Trump now plans to impose 32% reciprocal tariffs.
He further adds &#8216;I cannot believe they decided to just divide the trade deficit by imports and tell people that&#8217;s the tariff rate,&#8217; and wonders how U.S. Treasury Secretary Scott Bessent signed off on something like this. 
Why It Matters: Others are now waking up to these calculations, such as the <a href="https://x.com/Geiger_Capital/status/1907568233239949431">popular X finance influencer</a> Geiger Capital, and the Sri Lankan publication Economynext, which <a href="https://economynext.com/sri-lankas-88-pct-tax-on-us-arrived-at-by-dividing-trade-deficit-213077/">questioned</a> how the U.S. figures were calculated.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This guy cracked the tariff formula:<a href="https://twitter.com/orthonormalist?ref_src=twsrc%5Etfw">@orthonormalist</a> It's simply the nation's trade deficit with us divided by the nation's exports to us. Yes. Really. Vietnam: Exports 136.6, Imports 13.1 Deficit = 123.5 123.5/136.6 = 90% <a href="https://t.co/fDOMoQwzKt">pic.twitter.com/fDOMoQwzKt</a>
&mdash; Geiger Capital (@Geiger_Capital) <a href="https://twitter.com/Geiger_Capital/status/1907568233239949431?ref_src=twsrc%5Etfw">April 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Neither the White House nor the United States Trade Representative responded to Benzinga&#8217;s request for comments on this story at the time of writing.
The tariff announcements led to the U.S. futures tanking at the time of writing. The Dow Jones Industrial Average futures were seen 2.5% lower at 41,433 while the Nasdaq dropped 3.45% at 19,076.75.
Image via Shutterstock
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44620686/sp-500-nasdaq-futures-plunge-over-3-as-trumps-reciprocal-tariff-plan-hits-market-confidence">Trump&#8217;s &#8216;Reciprocal Tariff&#8217; Plan Hits Market Confidence As Dow Futures Drops Over 830 Points </a></li>
</ul>

General

Trump's 'Reciprocal Tariff' Math: A Masterclass In Economic Absurdity

Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) will release its third-quarter earnings results before the <a href="https://www.benzinga.com/quote/LW/earnings">opening bell on Thursday, April 3.</a>
Analysts expect the Eagle, Idaho-based company to report quarterly earnings at 87 cents per share, down from $1.2 per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Lamb Weston projects quarterly revenue at $1.49 billion, compared to $1.46 billion a year earlier.
On March 20, Lamb Weston declared a quarterly dividend of 37 cents per share.
Lamb Weston shares gained 1.6% to close at $54.15 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GBX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Barclays analyst Lauren Lieberman maintained an Overweight rating and cut the price target from $87 to $60 on Dec. 23, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Stifel analyst Matthew Smith maintained a Hold rating and cut the price target from $80 to $68 on Dec. 20, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Jefferies analyst Rob Dickerson maintained a Buy rating and raised the price target from $80 to $95 on Dec. 17, 2024. This analyst has an accuracy rate of 68%.</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and boosted the price target from $68 to $78 on Dec. 16, 2024. This analyst has an accuracy rate of 78%.</li>
<li>Deutsche Bank analyst Steve Powers initiated coverage on the stock with a Hold rating and a price target of $81 on Dec. 12, 2024. This analyst has an accuracy rate of 71%.</li>
</ul>
Considering buying LW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03031420/image-1-5-1024x574.png" alt="" class="wp-image-854653" style="width:583px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03031420/image-1-5-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03031420/image-1-5-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03031420/image-1-5-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03031420/image-1-5.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44604078/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

Top Wall Street Forecasters Revamp Lamb Weston Price Expectations Ahead Of Q3 Earnings

Legendary stock picker Warren Buffett has refused to include cryptocurrencies, including Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), in his firm Berkshire Hathaway Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) portfolio, but the holding company, interestingly, has exposure to a firm that pitches the apex cryptocurrency as an inflation hedge.
What happened: According to the latest 13F filing, Berkshire Hathaway holds 433,558 shares of financial services company Jefferies Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>), worth nearly $34 million.
The New York City-headquartered firm operates in investment banking and capital markets, and asset management businesses.
Notably, Jefferies holds a sizeable stake in iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), the world's largest spot exchange-traded Bitcoin fund. Filings with the SEC revealed that Jefferies owned 1,615,731 shares of IBIT, valued at over $85 million.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock">Bitcoin Reeling From Trump&#8217;s &#8216;Liberation Day&#8217; Shock But These Gold-Backed Coins Are Killing It This Year</a>
The investment likely stemmed from its bullish long-term view about the leading digital asset.
Jefferies deemed Bitcoin as a "critical hedge" against fiat debasement and inflation, <a href="https://www.cnbc.com/2023/10/05/bitcoin-is-a-critical-hedge-against-currency-debasement-and-return-of-inflation-jefferies-says.html">according </a>to an October 2023 report by CNBC.
The investment bank said Bitcoin's insurance policy narrative gained traction following the <a href="https://www.benzinga.com/news/23/06/32705921/us-banking-crisis-spurs-756-billion-capital-surge-into-cash-funds-says-bank-of-america">U.S. banking crisis</a> earlier in the year, and it recommended a 10% allocation to the asset for U.S. dollar-based long-term global investors.
This optimism sharply contrasted with Buffett&#8217;s dismissive attitude toward Bitcoin. The &#8220;Oracle of Omaha&#8221; called Bitcoin &#8220;probably rat poison squared&#8221; during Berkshire Hathaway&#8217;s annual&nbsp;<a href="https://www.benzinga.com/general/24/03/37513063/warren-buffett-says-he-wouldnt-pay-25-for-all-the-bitcoin-in-the-world-he-considers-crypto-rat-poiso" target="_blank" rel="noreferrer noopener">shareholder</a>&nbsp;meeting in 2018 and predicted a &#8220;bad ending&#8221; for the cryptocurrency.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $83,315.66, down 1.03% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, the asset has slid 11.84%.
Shares of Berkshire Hathaway fell 2.09% in after-hours trading, after closing 0.89% higher at 537.72 during Wednesday&#8217;s regular session. Jefferies stock closed 2.99% higher at $55.14.
Berkshire Hathaway stock demonstrated a good momentum and value score as of this writing. To see how Jefferies and other financial stocks rank in these categories, <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">visit </a>Benzinga Edge Stock Rankings.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="441" height="172" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03022349/Screenshot-2025-04-03-114944.png" alt="" class="wp-image-854549" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03022349/Screenshot-2025-04-03-114944.png 441w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03022349/Screenshot-2025-04-03-114944-300x117.png 300w" sizes="(max-width: 441px) 100vw, 441px" /></figure>
Image via Shutterstock
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44620779/onlyfans-founders-startup-and-hbar-foundation-enter-the-race-to-acquire-tiktok-us-to-maintain-american-ownership-and-governance">OnlyFans Founder&#8217;s Startup And HBAR Foundation Enter Race To Acquire Tiktok To Maintain &#8216;American Ownership And Governance&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

IBIT

Warren Buffett Avoids Bitcoin, But Do You Know Berkshire Hathaway Owns Stake In A Company That Pitches BTC As 'Critical' Inflation Hedge

Vinod Khosla, an early investor in OpenAI and the founder of Khosla Ventures, shared his views on what startup founders should expect from investors, criticizing the &#8220;founder-friendly&#8221; culture in the Silicon Valley.
What Happened: In a conversation on the Minus One podcast posted on Wednesday, Khosla said that while the term &#8220;founder-friendly&#8221; is often used in venture capital circles, it doesn't truly benefit entrepreneurs in the long run.
"I hate the culture — there&#8217;s a number of firms in the valley who push the idea we are founder friendly," he stated in response to a question about what founders should look for in investors. "What [it] really means, they're never going to challenge you. They want to be popular with you as opposed to help you."
See Also: <a href="https://www.benzinga.com/personal-finance/24/10/41196355/ai-will-do-most-jobs-better-faster-cheaper-silicon-valley-billionaire-vinod-khosla-calls-for-uni">AI Will Do Most Jobs &#8216;Better, Faster, Cheaper&#8217;: Silicon Valley Billionaire Vinod Khosla Calls For Universal Basic Income</a>
Khosla, who has been investing in startups for over 40 years, described his role as a &#8220;venture assistant,&#8221; not a traditional venture capitalist. He argued that successful investors don't just write checks but provide invaluable guidance, especially when a startup is incomplete in certain aspects.&nbsp;
"Great founders, the majority of the time, are incomplete in some dimension," he stated, adding, "Your job as an investor is to help them with that."
He also touched on the importance of &#8220;brutally honest&#8221; feedback, saying that 95% of the feedback founders get from investors is often &#8220;hypocritical politeness&#8221; that feels good but doesn't help their growth.&nbsp;
Founders should strive for a real, well-intended critique of their strategy, something that challenges them to think, he said.&nbsp;
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Why I Backed OpenAI, AGI, &amp; the Zero to One Team &#x7C; Vinod Khosla" width="500" height="281" src="https://www.youtube.com/embed/shMMW_RhztA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Why It Matters: As the founder of Khosla Ventures, Khosla has been instrumental in backing experimental technologies such as biomedicine, robotics, and AI. Notably, he was one of the early investors in OpenAI and <a href="https://www.benzinga.com/news/23/12/36056265/openai-investor-vinod-khosla-works-80-hours-a-week-will-use-peter-thiels-anti-aging-methods-if-they">invested $50 million</a> in the parent company of ChatGPT.
Khosla is also known <a href="https://www.benzinga.com/news/23/12/36056265/openai-investor-vinod-khosla-works-80-hours-a-week-will-use-peter-thiels-anti-aging-methods-if-they">for his involvement</a> in Sun Microsystems, which he co-founded in 1982. The company was later acquired by Oracle. Khosla's work at Kleiner Perkins, before founding his own venture fund, further cemented his reputation as a visionary investor in technology.
With a reported net worth of $7.7 billion, <a href="https://www.forbes.com/profile/vinod-khosla/">according</a> to Forbes, Khosla has built a career based on taking calculated risks in areas that other investors often overlook. His firm, Khosla Ventures, has backed major successes like Affirm and DoorDash.
Photo Courtesy: ahmad.faizal On Shutterstock.com
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41086806/elon-musk-mocks-vinod-khosla-after-openai-investor-mixes-up-argentinas-poverty-and-unemployment-rate">Elon Musk Mocks Vinod Khosla After OpenAI Investor Mixes Up Argentina&#8217;s Poverty And Unemployment Rates To Draw Parallels Between Javier Milei And Trump: &#8216;Vinod Is Just Actually Not Smart&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Vinod Khosla Was An Early Investor In OpenAI But He's No Fan Of Founder-Friendly Venture Capitalism: 'I Hate The Culture'

VSAT

Riyadh Air Taps Viasat For Industry-Leading Onboard Streaming And Wi-Fi, Elevating Premium Guest Experience

President Donald Trump has reportedly imposed reciprocal tariffs on some of the world&#8217;s most remote and uninhabited locations, along with various global trade partners, on &#8216;Liberation Day.&#8217;
What Happened: The Trump administration declared a 10% reciprocal tariff on the Heard and McDonald Islands, an uninhabited Australian external territory situated approximately 1,000 miles north of Antarctica, <a href="https://www.forbes.com/sites/antoniopequenoiv/2025/04/02/trump-imposes-tariffs-on-uninhabited-heard-and-mcdonald-islands-remotest-places-on-earth/">reported</a> Forbes.  The Australian government website describes these islands as &#8220;one of the wildest and remotest places on Earth&#8221;.
These tariffs also apply to other regions, including the British Indian Ocean Territory, the Cocos (Keeling) Islands, which have fewer than 600 residents, Norfolk Island, and the Norwegian Arctic islands of Svalbard and Jan Mayen, which have no permanent population.
The impact of these tariffs&nbsp;on the Heard and McDonald&nbsp;Islands remains uncertain due to their minimal economic activity, which is limited to some Australian commercial fishing in their economic zone.
See Also: <a href="https://benzinga.com/markets/equities/25/04/44620650/nvidia-amd-apple-meta-tesla-why-these-5-stocks-are-trending-on-trumps-liberation-day" target="_blank" rel="noreferrer noopener">Nvidia, AMD, Apple, Meta, Tesla: Why These 5 Stocks Are Trending On Trump&#8217;s Liberation Day </a>
Why It Matters: The imposition of tariffs on such remote and uninhabited locations raises questions about the rationale behind these decisions. For instance, Norfolk Island exported goods worth $655,000 to the U.S. in 2023, the main export being leather footwear worth $413,000, <a href="https://oec.world/en/profile/country/nfk">according </a>to Observatory of Economic Complexity data. However, the administrator of Norfolk Island, George Plant, refuted these figures and told The Guardian that there are no known exports from Norfolk Island to the U.S.
Similarly, the Heard Island and McDonald Islands, which are Australia&#8217;s &#8216;external territories&#8217;, reportedly exported products worth $1.4 million to the U.S. in 2022, primarily &#8220;machinery and electrical&#8221; imports, according to World Bank data. The nature of these goods remains unclear. In the previous five years, imports from these islands ranged from $15,000 to $325,000 per year.
The Australian prime minister, Anthony Albanese, told the publication, "Nowhere on earth is safe."<a href="https://www.theguardian.com/us-news/2025/apr/02/trump-new-tariffs-liberation-day"></a>
China has been <a href="https://www.benzinga.com/news/global/25/04/44620889/trumps-liberation-day-tariffs-roil-markets-as-china-slams-typical-unilateral-bullying-asian-markets-plunge">most affected</a> by Trump&#8217;s &#8216;Liberation Day&#8217; tariffs, with a 34% tax on top of the existing 20% tariffs on Chinese imports. Meanwhile,&nbsp;Canada and Mexico have been&nbsp;exempted from the baseline 10% tariff rate as the U.S. considers imposing&nbsp;a 25% tariff on the majority of imports from these countries. 
<ul>
<li>Read Next: <a href="https://benzinga.com/25/04/44621102/bytedance-alibaba-and-tencent-order-16-billion-worth-of-nvidias-h20-chips-following-the-surge-in-demand-deepseeks-low-cost-ai-models-report" target="_blank" rel="noreferrer noopener">ByteDance, Alibaba, And Tencent Order $16 Billion Worth Of Nvidia&#8217;s H20 Chips As Demand Surges For DeepSeek&#8217;s Low-Cost AI Models: Report </a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Imposes Tariffs On Uninhabited Islands And Remote Locations: World Bank Data Raises Questions

Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) will release its third-quarter earnings results before the <a href="https://www.benzinga.com/quote/CAG/earnings">opening bell on Thursday, April 3</a>.
Analysts expect the Chicago-based company to report quarterly earnings at 53 cents per share, down from 69 cents per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Conagra projects quarterly revenue at $2.9 billion, compared to $3.03 billion a year earlier.
Conagra Brands announced on Tuesday that it's teaming up with Bloom Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) to integrate advanced fuel cell technology at two of its Ohio manufacturing plants.
Conagra Brands shares fell 0.8% to close at $26.38 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/CAG/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Morgan Stanley analyst Megan Alexander initiated coverage on the stock with an Equal-Weight rating and a price target of $27 on March 24, 2025. This analyst has an accuracy rate of 64%.</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and cut the price target from $29 to $26 on March 6, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Stifel analyst Matthew Smith maintained a Hold rating and cut the price target from $28 to $26 on Feb. 19, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and cut the price target from $28 to $27 on Feb. 18, 2025. This analyst has an accuracy rate of 62%.</li>
<li>B of A Securities analyst Bryan Spillane maintained a Neutral rating and cut the price target from $31 to $29 on Dec. 20, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying CAG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="609" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03024517/image-28-1024x609.png" alt="" class="wp-image-854594" style="width:539px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03024517/image-28-1024x609.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03024517/image-28-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03024517/image-28-768x457.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03024517/image-28.png 1077w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44604078/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Conagra Brands Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Autoliv is entering two Virtual Power Purchase Agreements with the two renewable electricity producers, Alight and Eurowind Energy. They are important for ensuring a consistent and reasonably priced energy supply for Autoliv's activities in Europe, reducing the risks associated with potential future energy price fluctuations. Autoliv seeks to improve its energy resilience and ensure its operations will continue to be both economical and sustainable even in the face of volatile markets.

Autoliv Signs 12-Year Renewable Energy Agreements With Alight And Eurowind, Strengthening Energy Resilience And Climate Leadership

Mesoblast filed a request for a Type B meeting during the last quarter, in line with previous guidance, and expects to have the meeting during this quarter. The meeting will be held under Mesoblast's Regenerative Medicines Advanced Therapy (RMAT) designation for REVASCOR.
In a Type B meeting last year, FDA provided guidance to Mesoblast that the company was eligible to file for accelerated approval of REVASCOR in patients with end-stage HFrEF based on the totality of data across two randomized controlled trials. FDA also guided that a single confirmatory trial in class II/III patients with ischemic HFrEF and inflammation will need to be completed after any accelerated approval is obtained.

MESO

Reported Earlier, Mesoblast Files Type B FDA Meeting Request To Advance Revascor Toward Accelerated Approval In Ischemic Heart Failure With Inflammation

Preliminary First Quarter 2025 Results
<ul>
<li>Preliminary first quarter 2025 revenue is expected to be approximately $37.9 million, representing growth of 28% compared to the prior year period, and a decrease of 6% compared to the fourth quarter of 2024, driven by:
<ul>
<li>The sale of 27,579 Light Adjustable Lenses (LAL&#x2122;/LAL+&#xAE;); representing a 36% increase in procedure volume compared to the first quarter of 2024; and</li>
<li>The sale of 73 Light Delivery Devices (LDD&#x2122;s), bringing the installed base to 1,044 LDDs as of March 31, 2025, which represents a 43% expansion compared to the installed base of 732 LDDs at end of the first quarter of 2024</li>
</ul>
</li>
</ul>
Revised 2025 Guidance
The company decreased its 2025 full-year revenue and operating expense guidance as follows:
<ul>
<li>Revenue in the range of $160.0 million to $175.0 million, a decrease from the previous guidance range of $185.0 million to $197.0 million, representing implied growth of 14% to 25% compared to 2024;</li>
<li>Operating expenses in the range of $150.0 to $160.0 million, a decrease from the previous guidance range of $165.0 million to $170.0 million and now representing an implied increase of 10% to 18% compared to 2024;</li>
<li>Operating expenses also include non-cash stock-based compensation expense, which is now projected to be in the range of $27.0 million to $30.0 million, compared to the previous range of $22.0 million to $25.0 million.</li>
</ul>

RXST

Reported Earlier, RxSight Preliminary Q1 Results: Expects Revenue of $37.9M, Up 28% YoY (Vs. $40.14M Est.); Lowers 2025 Revenue Guidance To $160M–$175M (Vs. $188.9M Est.), Down From $185M–$197M

<ul>
<li>Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS (Risk Evaluation Mitigation Strategy) program1</li>
<li>Phase III data showed Vanrafia achieved proteinuria reduction of 36.1% (P&lt;0.0001) vs. placebo with improvements seen at Week 6 and sustained through Week 36 and favorable safety1,2</li>
<li>IgAN is a progressive, rare kidney disease; up to 50% of patients with persistent proteinuria progress to kidney failure within 10 to 20 years of diagnosis3-9</li>
<li>With third FDA approval in under 1 year across its renal portfolio, Novartis is uniquely positioned to lead a transformation in kidney care</li>
</ul>

Reported Earlier, Novartis Gains FDA Accelerated Approval For Vanrafia, The First Selective ETA Receptor Antagonist For Proteinuria Reduction In IgA Nephropathy

Reported Earlier, Sylvan Secures Strategic Investment From Novo Holdings To Accelerate Growth, With KKR Remaining Majority Shareholder

LCID

Lucid Group Prices $1B 5.00% Convertible Senior Notes Due 2030 In Private Offering

Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
<ul>
<li>Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease</li>
<li>Rilzabrutinib is currently under regulatory review in the US, EU and China for potential use in immune thrombocytopenia&nbsp;</li>
</ul>

FDA Grants Orphan Drug Status To Sanofi's Rilzabrutinib For Two Rare Autoimmune Diseases With High Unmet Needs

Press Releases

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

Management

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

Comments

Vaxart

매도 수량

Vaxart (NASDAQ:VXRT) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌